ask="0.5500"
ask_size="10000"
average_daily_volume="2869910"
bid="0.4700"
bid_size="3900"
book_value="0.1680"
change="-0.0715"
change_from_200_day_moving_average="0.1315"
change_from_50_day_moving_average="0.1509"
change_from_52_week_high="-0.6015"
change_From_52_week_low="0.1965"
change_in_percent="-13.0000%"
close="0.4785"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.2040"
ebitda="-41.64M"
eps_estimate_current_year="-0.1300"
eps_estimate_next_quarter="-0.0300"
eps_estimate_next_year="-0.1100"
ex_dividend_date="N/A"
float_shares="229462000"
high="0.5900"
high_52_weeks="1.0800"
last_trade_date="2/21/2017"
last_trade_price="0.4785"
last_trade_size="18875"
last_trade_time="4:00pm"
low="0.4600"
low_52_weeks="0.2820"
market_capitalization="123.04M"
moving_average_200_day="0.3470"
moving_average_50_day="0.3276"
name="Peregrine Pharmaceuticals Inc."
notes="N/A"
one_year_target_price="1.2500"
open="0.5800"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="+37.9022%"
percent_change_from_50_day_moving_average="+46.0413%"
percent_change_from_52_week_high="-55.6944%"
percent_change_from_52_week_low="+69.6808%"
previous_close="0.5500"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.2738"
price_per_sales="2.5964"
revenue="54.47M"
shares_outstanding="257141000"
short_ratio="0.6200"
stock_exchange="NCM"
symbol="PPHM"
volume="11896015"
weeks_range_52="0.2820 - 1.0800"
